Osaic Holdings’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Osaic Holdings’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-521	Closed	-$35K	–	7761
2022 Q3	$35K	Sell	521 -296	-36%	-$16.3K	﹤0.01%	5188
2022 Q2	$27K	Sell	817 -575	-41%	-$16.8K	﹤0.01%	5421
2022 Q1	$48K	Sell	1,392 -473	-25%	-$14.1K	﹤0.01%	5134
2021 Q4	$55K	Buy	1,865 +450	+32%	+$13.9K	﹤0.01%	5079
2021 Q3	$36K	Sell	1,415 -2,249	-61%	-$66.1K	﹤0.01%	5367
2021 Q2	$128K	Buy	3,664 +298	+9%	+$11.6K	﹤0.01%	4270
2021 Q1	$137K	Buy	3,366 +1,734	+106%	+$79.7K	﹤0.01%	4099
2020 Q4	$71K	Buy	1,632 +846	+108%	+$41.7K	﹤0.01%	4304
2020 Q3	$45K	Sell	786 -1,348	-63%	-$85.7K	﹤0.01%	4385
2020 Q2	$136K	Sell	2,134 -4,980	-70%	-$342K	﹤0.01%	3453
2020 Q1	$154K	Buy	+7,114	New	+$477K	﹤0.01%	3110

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Osaic Holdings's GBT Position: Q4 2022 in Review

Osaic Holdings sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 521 shares — an estimated $35K sold.

Osaic Holdings first reported a position in GBT in Q1 2020 and held it in 11 quarters. The position peaked at $154K in Q1 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Osaic Holdings reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Osaic Holdings sold 521 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $35K.
Osaic Holdings first reported a position in Global Blood Therapeutics, Inc. in Q1 2020 and held it in 11 quarters.
Osaic Holdings's Global Blood Therapeutics, Inc. position peaked at $154K in Q1 2020.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Osaic Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.